Lung Injury, Acute: Clinical Trials

5 trials for Lung Injury, Acute, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 completed. 5 Phase 2, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 25Completed 5
Phase 11Completed 1

Follow Lung Injury, Acute: new trials by email Literature Review of Lung Injury, Acute trials Research Report on Lung Injury, Acute

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Nebulised Heparin to Reduce COVID-19 Induced Acute Lung Injury
Nebulised heparin - Covid19, ARDS, Human
Phase 1 / Phase 2CompletedUniversity College Hospital Galway402020-12-232024-07-24
SAFEty Study of Early Infusion of Vitamin C for Treatment of Novel Coronavirus Acute Lung Injury (SAFE EVICT CORONA-ALI)
L-ascorbic acid, Placebo - COVID-19, Lung Injury, Acute
Phase 2CompletedVirginia Commonwealth University472020-12-182024-04-04
The Safety, Tolerability, PK and PD of GSK2586881 in Patients With Acute Lung Injury
Dose 1 GSK2586881, Dose 2 GSK2586881, Dose 3 GSK2586881 - Lung Injury, Acute
Phase 2CompletedGlaxoSmithKline442012-09-012017-09-28
SB-681323 IV for Subjects at Risk of Acute Lung Injury or ARDS
SB-681323 Intravenous 3mg, SB-681323 Intravenous 7.5 mg, SB-681323 Intravenous 7.5mg - Lung Injury, Acute
Phase 2CompletedGlaxoSmithKline772009-10-162017-10-18
Study of Enbrel (Etanercept) for the Treatment Sub-Acute Pulmonary Dysfunction After Allogeneic Stem Cell Transplant
Etanercept - Lung Injury, Acute, Respiratory Distress Syndrome, Adult
Phase 2CompletedUniversity of Michigan Rogel Cancer Center342003-10-012015-12-03

Narrower conditions

Acute Lung Injury (5)  ·  Respiratory Distress Syndrome (4)  ·  COVID-19 (2)  ·  Bronchiolitis Obliterans (1)  ·  Lung Injury (1)

Broader conditions

Lung Diseases (5)  ·  Respiratory Tract Diseases (5)  ·  Lung Injury (4)  ·  Respiration Disorders (4)  ·  Coronaviridae Infections (2)  ·  Coronavirus Infections (2)  ·  Infections (2)  ·  Nidovirales Infections (2)  ·  Pneumonia (2)  ·  Pneumonia, Viral (2)  ·  RNA Virus Infections (2)  ·  Respiratory Tract Infections (2)  ·  Virus Diseases (2)  ·  Bronchial Diseases (1)  ·  Bronchiolitis (1)

Interventions

Ascorbic Acid (1)  ·  Etanercept (1)  ·  Sodium Chloride (1)

Sponsors

GlaxoSmithKline (2)  ·  University College Hospital Galway (1)  ·  University of Michigan Rogel Cancer Center (1)  ·  Virginia Commonwealth University (1)

Countries

United States (4)  ·  Canada (1)  ·  Ireland (1)

Top investigators

Brian Davis, MD (1)  ·  Gregory A Yanik, MD (1)  ·  John Laffey (1)

Results publications

PMID 22155140, PMID 26102252, PMID 28877748, PMID 36104785